1. Mekras JA, Boothman DA, Perez LM, Greer S (1984) Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies. Cancer Res 44(6):2551–2560
2. Boothman DA, Briggle TV, Greer S (1987) Tumor-selective metabolism of 5-fluoro-2’-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma. Cancer Res 47(9):2354–2362
3. Boothman DA, Briggle TV, Greer S (1987) Protective, tumor-selective dual pathway activation of 5-fluoro-2’-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755. Cancer Res 47(9):2344–2353
4. Kaysen J, Spriggs D, Kufe D (1986) Incorporation of 5-fluorodeoxycytidine and metabolites into nucleic acids of human MCF-7 breast carcinoma cells. Cancer Res 46(9):4534–4538
5. Smith SS, Kaplan BE, Sowers LC, Newman EM (1992) Mechanism of human methyl-directed DNA methyltransferase and the fidelity of cytosine methylation. Proc Natl Acad Sci USA 89(10):4744–4748